You may be eligible for a clinical study investigating a potential new treatment for MASH, a serious liver condition linked to weight, blood pressure, cholesterol and diabetes.
If you meet the criteria, we will support you every step of the way.
At CDH Research Institute, we believe the people who participate in clinical trials are the quiet heroes behind every medical breakthrough. Our purpose-built facility in Maroochydore is home to a dedicated team of experienced clinicians, coordinators, and support staff, all focused on making your experience as a trial participant as smooth, respectful, and meaningful as possible.
Whether you’re living with a health condition and looking for new options, chat to our team today.
If you qualify and choose to take part, all study-related visits, care and study medicines are provided at no cost to you, and travel reimbursement may be available.
If you’re living with MASH (or at risk of it), this study could be a meaningful next step. The MASH studies are testing whether a new investigational drug, efimosfermin alfa, can safely help improve liver health. You’d be receiving close, expert care throughout and contributing to research that could shape future MASH treatments.
MASH
MASH (Liver Disease)
GSK
1 year or 4 years
Maroochydore, QLD
18 to 75 years
We don’t just run clinical trials. We build relationships with every participant who walks through our doors.
Our clinic in Maroochydore was designed specifically for clinical research, giving you a comfortable, professional environment for every visit.
You’ll work with the same coordinators, and support staff throughout your entire study. No surprises, no unfamiliar faces.
We make sure you understand every step before you take it. Informed consent isn’t just a form, it’s an ongoing conversation.
CDH Research Institute has been conducting ethical, high-quality clinical research on the Sunshine Coast for close to a decade across a wide range of therapeutic areas.
Every study we run is rigorously reviewed and approved to the highest regulatory standards. Your safety is always our first priority.
We run trials across a wide range of health conditions, so whether you qualify today or further down the track, there’s likely a study here for you.
We’ll be in touch within one business day. No commitment required.
CDH Research Institute is a specialist research practice built on one belief: that every participant deserves the same warmth, precision, and respect you’d expect from your own GP, delivered by a team that knows you by name. We understand the time and trust you place in us, and we work hard to make every interaction count.
Monday: 9am – 4pm
Tuesday: 9am – 4pm
Wednesday: 9am – 4pm
Thursday: 9am – 4pm
Friday: 8:30am – 12pm
Joining a clinical trial is one of the most meaningful contributions you can make to your own health and your community.
Our team is here to answer every question before you decide anything.
We know the idea of a clinical trial can feel daunting. Here’s exactly how the process works, step by step.
Fill in the short form or call us. There’s no obligation. We just want to understand which study you’re interested in and capture some basic details.
One of our coordinators will contact you to ask a few eligibility questions over the phone. This usually takes less than 10 minutes.
If you appear to be a suitable candidate, we’ll invite you in for a formal screening visit. This may include a brief review of your medical history, simple tests, and a full explanation of the study.
Before anything begins, you’ll sit down with our investigator to go through the study in full detail. You can ask every question you have and have all your questions answered. Participation is completely voluntary.
You’ll follow a scheduled visit plan with our team by your side every step of the way. We’ll manage your timeline, keep you informed, and support you throughout.
Once your participation concludes, our team will guide you through the follow-up phase and keep you in the loop on any outcomes.
Got questions? We’ve answered the most common ones below. If you need more info, just enquire and we’ll be happy to help.
Clinical research studies investigating efimosfermin alfa, an investigational drug for people with (or at risk for) MASH. The studies are looking at how safe the drug is and whether it may help improve liver health.
The study involves monthly dosing and regular health assessments. Our team will walk you through the full duration before you commit to anything.
After health checks confirm you’re suitable, you’ll receive the study drug (efimosfermin alfa or placebo) each month and complete regular assessments with our team. You’ll also receive expert lifestyle guidance to support your liver health.
A clinical research study is a medical study that helps answer important questions about investigational medicines, such as: is it safe, does it work, and are there side effects. All medicines must be tested in clinical research studies before they can be approved for doctors to prescribe.
Efimosfermin alfa is the investigational drug being tested in the MASH studies. It’s being researched to see whether it can safely help improve liver health in people with MASH.
Yes. With your consent, we keep your GP updated throughout the study.
